Skip to content

The Viability of Microdosing Psychedelics as a Strategy to Enhance Cognition and Well-being - An Early Review.

Joel Bornemann

Journal of Psychoactive Drugs 2020 DOI: 10.1080/02791072.2020.1761573 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Review Peer reviewed
Intervention Microdosing
Topics Microdosing
Keywords Cognitive enhancements Psychedelics Well-being
Key findings Microdosing may improve mood, focus, and creativity, but null reports and negative effects like anxiety also occur, and methodological limitations prevent definitive conclusions.

Abstract

Psychedelic substances are currently experiencing a renaissance in interest for both therapeutic as well as recreational applications. It has been proposed that microdosing, i.e., ingesting sub-perceptual doses of a psychedelic, could confer some of the benefits of these substances to users while minimizing the risks associated with full-dose use. This review aimed to summarize and examine the extant literature on psychedelic microdosing. Exploratory evidence published to date indicates a variety of benefits reported by microdosers including improvements in mood, focus, and creativity, with some null reports, and a minority of people reporting selective negative consequences such as increased anxiety and physiological discomfort. Methodological limitations of current evidence, however, make definitive conclusions hard to draw. Recommendations for future research are given.

Explore topics